Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Neuromodulation Treatments for Chronic Pain: Assessing and Predicting the Effects of Personalized High-Definition Protocols for Transcranial Direct Current Stimulation (HD-tDCS)

NCT07432841 is registered in ClinicalTrials.gov with Istituti Clinici Scientifici Maugeri SpA as lead sponsor.

NCT NCT07432841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07432841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Neuromodulation Treatments for Chronic Pain: Assessing and Predicting the Effects of Personalized High-Definition Protocols for Transcranial Direct Current Stimulation (HD-tDCS)
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
Phase
Not applicable
Overall status
Recruiting
Start date
April 3, 2025
Completion date
May 31, 2027
Enrollment
144 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain